Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 381564, 8 pages
http://dx.doi.org/10.1155/2011/381564
Review Article

Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets

Department of Orthopaedics, College of Physicians and Surgeons, Columbia University, Black Building, 14-1412, 650 West 168th Street, New York, NY 10032, USA

Received 29 August 2010; Accepted 15 November 2010

Academic Editor: Alberto Pappo

Copyright © 2011 Anne C. Onishi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Tzu, The Art of War, El Paso Norte Press, El Paso, Tex, USA, 2005.
  2. http://www.mayoclinic.org/chondrosarcoma/.
  3. S. W. Sung, R. Fabrizio, and F. Y. Lee, “Chondrosarcoma,” in Orthopedic Knowledge Update Musculoskeletal Tumors 2, S. Herbert and M. D. Schwartz, Eds., pp. 185–195, American Academy of Orthopedic Surgeons, 2007. View at Google Scholar
  4. F. Y. Lee, H. J. Mankin, G. Fondren, M. C. Gebhardt, D. S. Springfield, A. E. Rosenberg, and L. C. Jennings, “Chondrosarcoma of bone: an assessment of outcome,” Journal of Bone and Joint Surgery A, vol. 81, no. 3, pp. 326–338, 1999. View at Google Scholar · View at Scopus
  5. P. Garzino-Demo, G. Tanteri, and G. Tanteri, “Chondrosarcoma of the temporomandibular joint: a case report and review of the literature,” Journal of Oral and Maxillofacial Surgery, vol. 68, no. 8, pp. 2005–2011, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. N. Kawahara, K. Tomita, H. Murakami, S. Demura, K. Yoshioka, and T. Miyazaki, “Total excision of a recurrent chondrosarcoma of the thoracic spine: a case report of a seven-year-old boy with fifteen years follow-up,” Spine, vol. 35, no. 11, pp. E481–E487, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Wesolowski and G. T. Budd, “Use of chemotherapy for patients with bone and soft-tissue sarcomas,” Cleveland Clinic Journal of Medicine, vol. 77, supplement 1, pp. S23–S26, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. R. Rosier, R. J. O'Keefe, and R. J. O'Keefe, “P-glycoprotein expression in cartilaginous tumors,” Journal of Surgical Oncology, vol. 65, no. 2, pp. 95–105, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. Terek, G. K. Schwartz, K. Devaney, L. Glantz, S. Mak, J. H. Healey, and A. P. Albino, “Chemotherapy and P-glycoprotein expression in chondrosarcoma,” Journal of Orthopaedic Research, vol. 16, no. 5, pp. 585–590, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Kawakami, T. Matsumoto, K. Kuribayashi, and T. Tamaki, “Multidrug resistance-1 and P-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance,” Journal of Orthopaedic Research, vol. 17, no. 6, pp. 935–940, 1999. View at Google Scholar
  11. J. Asp, L. Sangiorgi, S. E. Inerot, A. Lindahl, L. Molendini, M. S. Benassi, and P. Picci, “Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues,” International Journal of Cancer, vol. 85, no. 6, pp. 782–786, 2000. View at Publisher · View at Google Scholar
  12. D. W. Kim, K. O. Kim, M. J. Shin, J. H. Ha, S. W. Seo, J. Yang, and F. Y. Lee, “siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells,” Molecular Cancer, vol. 8, article 28, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. M. Chaudhary and I. B. Roninson, “Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs,” Journal of the National Cancer Institute, vol. 85, no. 8, pp. 632–639, 1993. View at Google Scholar
  14. M. Z. Levy, R. C. Allsopp, A. B. Futcher, C. W. Greider, and C. B. Harley, “Telomere end-replication problem and cell aging,” Journal of Molecular Biology, vol. 225, no. 4, pp. 951–960, 1992. View at Publisher · View at Google Scholar
  15. J. W. Shay and S. Bacchetti, “A survey of telomerase activity in human cancer,” European Journal of Cancer Part A, vol. 33, no. 5, pp. 787–791, 1997. View at Publisher · View at Google Scholar
  16. J. A. Martin, B. R. DeYoung, S. Gitelis, J. A. Weydert, A. J. Klingelhutz, G. Kurriger, and J. A. Buckwalter, “Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy,” Clinical Orthopaedics and Related Research, no. 426, pp. 117–124, 2004. View at Publisher · View at Google Scholar
  17. J. A. Martin, E. Forest, and E. Forest, “Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation,” Cell Growth and Differentiation, vol. 13, no. 9, pp. 397–407, 2002. View at Google Scholar
  18. D. Parsch, U. Brassat, T. H. Brummendorf, and J. Fellenberg, “Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines,” Cancer Investigation, vol. 26, no. 6, pp. 590–596, 2008. View at Publisher · View at Google Scholar · View at PubMed
  19. C. Harley, “Telomerase and cancer therapeutics,” Nature Reviews—Cancer, vol. 8, pp. 167–179, 2008. View at Google Scholar
  20. T. Kubo, T. Sugita, S. Shimose, T. Matsuo, K. Arihiro, and M. Ochi, “Expression of hypoxia-inducible factor-1α and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours,” Journal of Bone and Joint Surgery - Series B, vol. 90, no. 3, pp. 364–370, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. C. Lin, R. McGough, B. Aswad, J. A. Block, and R. Terek, “Hypoxia induces HIF-1α and VEGF expression in chondrosarcoma cells and chondrocytes,” Journal of Orthopaedic Research, vol. 22, no. 6, pp. 1175–1181, 2004. View at Publisher · View at Google Scholar · View at PubMed
  22. F. M. Klenke, A. Abdollahi, E. Bertl, M. M. Gebhard, V. Ewerbeck, P. E. Huber, and A. Sckell, “Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo,” BMC Cancer, vol. 7, article 49, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. H. Morioka, L. Weissbach, T. Vogel, G. P. Nielsen, G. T. Faircloth, LI. Shao, and F. J. Hornicek, “Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis,” Clinical Cancer Research, vol. 9, no. 3, pp. 1211–1217, 2003. View at Google Scholar
  24. S. Pallu, P. J. Francin, and P. J. Francin, “Obesity affects the chondrocyte responsiveness to leptinin patients with osteoarthritis,” Arthritis Research & Therapy, vol. 12, p. R112, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. Y. M. Schrage, I. Machado, and I. Machado, “COX-2 expression in chondrosarcoma: a role for celecoxib treatment?” European Journal of Cancer, vol. 46, no. 3, pp. 616–624, 2010. View at Publisher · View at Google Scholar · View at PubMed
  26. M. Endo, T. Matsumura, and T. Matsumura, “Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas,” Human Pathology, vol. 37, no. 4, pp. 471–476, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. D. Santini, B. Vincenzi, and B. Vincenzi, “Pamidronate induces modifications of circulating angiogenetic factors in cancer patients,” Clinical Cancer Research, vol. 8, no. 5, pp. 1080–1084, 2002. View at Google Scholar
  28. B. Kubista, K. Trieb, and K. Trieb, “Anticancer effects of zoledronic acid against human osteosarcoma cells,” Journal of Orthopaedic Research, vol. 24, no. 6, pp. 1145–1152, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. L. Montella, R. Addeo, and R. Addeo, “Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 7, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. T. Kubo, S. Shimose, T. Matsuo, K. Tanaka, Y. Yasunaga, A. Sakai, and M. Ochi, “Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells,” Journal of Orthopaedic Research, vol. 24, no. 6, pp. 1138–1144, 2006. View at Publisher · View at Google Scholar · View at PubMed
  31. A. M. Cleton-Jansen, H. M. Van Beerendonk, H. J. Baelde, J. V. G. M. Bovée, M. Karperien, and P. C. W. Hogendoorn, “Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma,” Clinical Cancer Research, vol. 11, no. 22, pp. 8028–8035, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. H. M. van Beerendonk, L. B. Rozeman, A. H. M. Taminiau, R. Sciot, J. V. M. G. Bovée, A. M. Cleton-Jansen, and P. C. W. Hogendoom, “Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression,” Journal of Pathology, vol. 202, no. 3, pp. 359–366, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. O. L. Bohn, M. Fuertes-Camilo, L. Navarro, J. Saldivar, and S. Sanchez-Sosa, “p16 INK4a expression in basal-like breast carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 3, no. 6, pp. 600–607, 2010. View at Google Scholar
  34. P. M. Weinberger, Z. Yu, and Z. Yu, “Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer,” Clinical Cancer Research, vol. 10, no. 17, pp. 5684–5691, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. F. Moussavi-Harami, A. Mollano, J. A. Martin, A. Ayoob, F. E. Domann, S. Gitelis, and J. A. Buckwalter, “Intrinsic radiation resistance in human chondrosarcoma cells,” Biochemical and Biophysical Research Communications, vol. 346, no. 2, pp. 379–385, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. E. A. Chiocca, “Oncolytic viruses,” Nature Reviews Cancer, vol. 2, no. 12, pp. 938–950, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. A. Koski, L. Kangasniemi, and L. Kangasniemi, “Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF,” Molecular Therapy, vol. 18, no. 10, pp. 1874–1884, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. D. W. Kim, S. W. Seo, and S. W. Seo, “Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of grade II chrondrosarcoma cells,” Journal of Orthopaedic Research, vol. 25, no. 6, pp. 820–828, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. A. Y. Bedikian, M. Millward, and M. Millward, “Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4738–4745, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. N. Wiedenmann, M. Koto, U. Raju, L. Milas, and K. A. Mason, “Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide,” Investigational New Drugs, vol. 25, no. 5, pp. 411–416, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. K. W. Yip, J. D. Mocanu, and J. D. Mocanu, “Combination Bcl-2 antisense and radiation therapy for nasopharyngeal cancer,” Clinical Cancer Research, vol. 11, no. 22, pp. 8131–8144, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. J. Frank and U. Selek, “Proton beam radiation therapy for head and neck malignancies,” Current Oncology Reports, vol. 12, no. 3, pp. 202–207, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. C. Ares, E. B. Hug, and E. B. Hug, “Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 4, pp. 1111–1118, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus